Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.578, 2009-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Capecitabine cuts complication costs in colorectal cancer
Reactions Weekly, Vol. 1, Iss. 1252, 2009-01 ,pp. :
Access to resources
Recommend
Costs of taxanes, capecitabine, quantified for breast cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 595, 2010-01 ,pp. :
Capecitabine proves its worth in colorectal, breast cancer
Inpharma, Vol. 1, Iss. 1345, 2002-01 ,pp. :
Capecitabine equivalent to IV fluorouracil in colorectal cancer
Inpharma, Vol. 1, Iss. 1316, 2001-01 ,pp. :
Capecitabine proves its worth in colorectal, breast cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 369, 2002-01 ,pp. :